HighTower Advisors, LLC - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 30 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2021$48,000
-5.9%
28,4650.0%0.00%
Q2 2021$51,000
+54.5%
28,465
+84.1%
0.00%
Q1 2021$33,000
-58.2%
15,465
-57.1%
0.00%
Q4 2020$79,000
-6.0%
36,065
+14.1%
0.00%
Q3 2020$84,000
-22.9%
31,615
+14.8%
0.00%
-100.0%
Q2 2020$109,000
+738.5%
27,540
+82.5%
0.00%
Q1 2020$13,000
-27.8%
15,0900.0%0.00%
Q4 2019$18,000
+63.6%
15,090
+15.3%
0.00%
Q3 2019$11,000
+120.0%
13,090
-0.4%
0.00%
Q2 2019$5,00013,1420.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q1 2020
NameSharesValueWeighting ↓
FNY Investment Advisers, LLC 199,220$151,0000.12%
Allred Capital Management, LLC 20,528$15,0000.01%
PATHSTONE FAMILY OFFICE, LLC 10,050$8,0000.00%
LifePlan Financial Group, Inc 1,440$1,0000.00%
VICTORY CAPITAL MANAGEMENT INC 4,806$4,0000.00%
UBS Group AG 105$00.00%
Sowell Financial Services LLC 2,819$2,0000.00%
IFP Advisors, Inc 50$00.00%
OSAIC HOLDINGS, INC. 6$00.00%
Jacobi Capital Management LLC 1,000$1,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders